Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Urara Kudo
Institution:
Gifu Pharmaceutical University
Observed institution:
Gifu Pharmaceutical University
ORCID:
0009-0009-2048-4771
Observed ORCID:
0009-0009-2048-4771
OpenAlex ID:
A5095070801
Linagliptin decreased the tumor progression on glioblastoma model
2024
·
Shohei Tsuji
, Urara Kudo
, et al.
·
Biochemical and Biophysical Research Communications
·
12
The role of progranulin in macrophages of a glioblastoma model
2024
·
Shohei Tsuji
, Urara Kudo
, et al.
·
Journal of Neuro-Oncology
·
8
Intranasal administration of liposomes: Potential brain delivery with prospective ophthalmic reach
2024
·
Shohei Tsuji
, Riku Hatano
, et al.
·
Journal of Drug Delivery Science and Technology
·
2
Synergistic antitumor and radiosensitizing effects of α-sulfoquinovosyl-acylpropanediol (SQAP) via PI3K/Akt inhibition and DNA repair impairment in glioblastoma
2025
·
Takayuki Nishiwaki
, Urara Kudo
, et al.
·
Journal of Neuro-Oncology
·
1
Griseofulvin as a dual-action agent against glioblastoma: anti-tumor effect and enhancement of 5-ALA photodynamic diagnosis in stem-like cells
2026
·
Takayuki Nishiwaki
, Takumi Yamada
, et al.
·
Cancer Treatment and Research Communications
PDF
Show more works
View as search
Works count:
5
Citation count:
23
H-index:
2
I10-index:
1
Year
Topic
Type
